Aminoimidazole ribonucleotide structure

This chemistry seems less probable, however, given the structural similarity of the smPurL proteinand aminoimidazole ribonucleotide (AIR) synthetase (PurM), another enzyme in the purine biosynthetic pathway that is known to form an iminophosphate intermediate (Scheme 16). Under in vitro conditions, FGAR-AT can use ammonia as an alternate nitrogen source when glutamine is absent. 

Independent of the actual mechanism, functional divergence between two proteins with a common ancestor is exemplified in the /la-barrel structures of N-(phosphor-ibosyl-formimino)-aminoimidazole-carboxamide ribonucleotide isomerase (HisA) and imidazole glycerol phosphate synthase (HisF) of the histidine biosynthetic pathway [16]. The hypothesis of a common origin of the two enzymes was formulated based on sequence comparison [17] and has recently found support by the identification of extensive structural similarities [18],... 

A few steps convert inosinate into either AMP or GMP (Figure 25,9). Adenylate is synthesized from inosinate by the substitution of an amino group for the carbonyl oxygen atom at C-6. Again, the addition of aspartate followed by the elimination of fumarate contributes the amino group. GXP, rather than ATP, is the phosphoryl-group donor in the synthesis of the adenylosuccinate intermediate from inosinate and aspartate. In accord with the use of GTP, the enzyme that promotes this conversion, adenylsuccinate synthase, is structurally related to the G-protein family and does not contain an ATP-grasp domain. The same enzyme catalyzes the removal of fumarate from adenylosuccinate in the synthesis of adenylate and from 5-aminoimidazole-4-jV-succinocarboxamide ribonucleotide in the synthesis of inosinate. 

The possibility that the iV °-formyl derivative (III.163) might serve as a substrate for two important enzymes of the de novo purine pathway that utilize reduced folates as their natural substrates, namely 5-aminoimidazole-4-car-boxamide ribonucleotide (AICAR) transformylase and glycinamide ribonucleotide (GAR) transformylase, was examined [61]. While the affinity of (III. 163) (AT, (app) = 29/xM) for AICAR transformylase appeared to be greater than that of the natural substrate 10-formyltetrahydrofolate (A (app) = 68 /xM), the reaction was slow, resulting in a 750-fold lower Frei/Am(app) ratio for the quinazoline. The affinity of (III. 163) (/frn(app) = 1.9 /xM) for GAR transformylase was likewise several times greater than that of the natural substrate, in this case 5,10-methenyltetra-hydrofolate (/if,n(app) = 8.9/xM). However, (III. 163) was also used rather efficiently in the reaction by GAR transformylase, resulting in a 4-fold higher V.J Ai, (app) for the quinazoline than for 5,10-methenyltetrahydrofolate. The authors concluded from these results that the 5,10-methenyl structure is not needed for GAR transformylase activity. 

---